Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo

Schofield, Irving, Calo, Bogstedt, Rees, Nuccitelli, Narwal, Petrone, Roberts, Brown, Cusdin, Dosanjh, Lloyd, Dobson, Gurrell, Fraser, McFarlane, Rockenstein, Spencer, Masliah, Spillantini, Tan, Billinton, Vaughan, Chessell, Perkinton (2019) Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo Neurobiol Dis (IF: 6.1) 132 104582

Links

http://www.ncbi.nlm.nih.gov/pubmed/31445162
http://dx.doi.org/10.1016/j.nbd.2019.104582

Similar articles

Tools